3i Group, a multinational private equity and venture capital company, completed the acquisition of Cellon, a manufacturer of single-use products for bioprocessing, storage, and transport of sterile solutions. Financial terms were not disclosed. "We are excited to work with 3i given its international team and shared vision for opportunities to support Cellon’s continued growth and complement its product offering and geographic footprint. We believe they will be a great partner for us as we look to expand our production capacity and portfolio of innovative and high quality products," Richard Fry, Cellon CEO.